Q2 2019 Holdings
Filed 2019-08-14 | 6 holdings | $225.4K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-05-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Akero Therapeutics Inc(AKRO)A | COM | 00973Y108 | $75.7K | 3,954,858 | 33.6% |
| Precision Biosciences IncA | COM | 74019P108 | $56.5K | 4,265,141 | 25.1% |
| Turning Point Therapeutics IA | COM | 90041T108 | $54.5K | 1,340,265 | 24.2% |
| Apellis Pharmaceuticals Inc(APLS)A | COM | 03753U106 | $25.3K | 1,000,000 | 11.2% |
| Apellis Pharmaceuticals, Inc | COM | 037530106 | $25.3K | 1,000,000 | 11.9% |
| Menlo Therapeutics Inc | COM | 586858102 | $8.8K | 1,461,552 | 3.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.5K | 875,000 | 2.0% |